Suppr超能文献

预防癌症:人乳头瘤病毒疫苗在普通人群中的作用

[Preventing cancer: The role of Papillomavirus vaccination in the general population].

作者信息

Vié le Sage François, Cohen Robert

机构信息

(AFPA) Association Française de Pédiatrie Ambulatoire, cabinet de pédiatrie, 67, rue Alexandre-Dumas, 73100 Aix-les-Bains, France.

Infovac, CHI de Créteil, 40, avenue de Verdun, 94000 Créteil, France.

出版信息

Bull Cancer. 2020 Jan;107(1):10-20. doi: 10.1016/j.bulcan.2019.12.006. Epub 2020 Jan 22.

Abstract

Papillomavirus (HPV), the first sexually transmitted disease in the world, is the main infectious agent responsible for cancer (6300 per year, in France). The cycle of HPV infection - >precancerous lesions - >cancer is well documented with regard to the cervix (cf. Nobel Prize in 2008). While this area is the most frequent (3000), it is far from being the only one. Other cancers include the anus, oropharyngeal sphere, glans and vulva. The sum of these other induced HPV cancers is greater than the total number of cervical cancers and also concerns boys. Screening is essential but insufficient and only concerns the cervix. Only vaccination can provide primary and general prevention. Since 2007, there have been many studies demonstrating its excellent efficacy and tolerance. However, France lags behind other countries with a vaccination coverage (<30 %) that does not allow for an epidemiological impact.

摘要

人乳头瘤病毒(HPV)是世界上第一种性传播疾病,是导致癌症的主要传染因子(在法国,每年有6300例)。HPV感染→癌前病变→癌症的循环在子宫颈方面已有充分记录(参见2008年诺贝尔奖)。虽然这个部位是最常见的(3000例),但远非唯一受影响的部位。其他癌症包括肛门、口咽区域、阴茎头和外阴。这些其他由HPV引发的癌症总数超过子宫颈癌的总数,并且也涉及男性。筛查至关重要但并不充分,且仅针对子宫颈。只有接种疫苗才能提供一级和全面预防。自2007年以来,有许多研究证明了其卓越的疗效和耐受性。然而,法国落后于其他国家,其疫苗接种覆盖率(<30%)无法产生流行病学影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验